Recent Finacing
Recent Raise
Cage Bio is a clinical-stage biotech developing infection, inflammation, and immunology therapies and consumer products via a proprietary deep-eutectic ionic-liquid platform, advancing a rosacea candidate to Phase 2.
Focus Areas
Total Raised
Funding round
See the team members at Cage Bio.
